TELA Bio, Inc.TELANASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-42.58M
↓ 37% below average
Average (7y)
$-31.07M
Historical baseline
Range
High:$-16.48M
Low:$-42.62M
CAGR
+14.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-42.58M | -2.7% |
| 2023 | $-41.47M | +2.7% |
| 2022 | $-42.62M | -37.2% |
| 2021 | $-31.06M | -26.1% |
| 2020 | $-24.62M | +12.7% |
| 2019 | $-28.22M | -31.3% |
| 2018 | $-21.49M | -30.4% |
| 2017 | $-16.48M | - |